Esra Cakar

Service Area
Modeling & Meta-Analysis
Research Analyst
Rotterdam, The Netherlands

​Esra is a Research Analyst in the Modeling and Meta-Analysis department at the office in Rotterdam, the Netherlands. She supports the team in cost-effectiveness and budget impact model development and adaptation, meta-analysis and literature reviews.

Esra holds a bachelor degree in Health Policy and Management and a master degree in Health Economics, both obtained from Erasmus University. During her bachelor, she won a thesis award for her research on the application of multi criteria decision analysis in the Dutch reimbursement system. In this study, she used the MCDA framework to systematically compare the oncology drug nivolumab (lung cancer and melanoma) with ipilimumab (melanoma), nintedanib (lung cancer) and evolocumab (primary hypercholesterolemia) based on their performance on multiple reimbursement criteria. For her master thesis, she developed a cost-effectiveness model for atezolizumab in non-small cell lung cancer patients in the Netherlands. Esra has worked as a researcher at the Erasmus School of Health Policy and Management, where she conducted a study about the complexity of care between academic, top-clinical and general hospitals.

2018-09-21T04:12:47+00:00 April 13th, 2018|